Changes in the C-type Natriuretic peptide (CNP) and NO derivatives in the plasma and CSF of the patients with subarachnoid hemorrhage (SAH)
Keisuke Ikeda, Toshiaki Ikeda, T Onizuka, Hiroo Terashi, Toru Nakanishi, Tadaharu Fukuda, S Endo · Critical Care · 2000
Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.
Critical Care · BioMed Central · conference-abstract · 2000
Abstract
CNP levels in the CSF on day 1 of hospitalization was higher than that of the reference patients and the level decreased significantly on day 7, but we did not observe any significant difference between the groups. CNP levels in the plasma did not change. NOx levels in the CSF in the week following SAH were higher than the levels of the reference patients, and the level in Group A was higher than in Group B on day 1. Only in Group A did NOx levels decrease significantly from day 3. NOx levels in the plasma did not change significantly. CNP levels in the CSF were high in the acute phase following SAH, while plasma CNP levels were maintained at a constant.
But any specific role of CNP for cerebral vasospasm was not indicated from our findings. We considered that NOx in the CSF has a role as an inhibitor for cerebral vasospasm following SAH, because NOx levels decreased significantly only in the vasospasm group, while plasma NOx levels did not change significantly.
Open the resolved locator · 10.1186/cc899
Metadata licence: OpenAlex metadata (CC0)